Heart failure after acute ST-segment elevation myocardial infarction: What should we do about it?

Clinical Cardiology

Volumn 28, Issue 8, 2005, Pages 360-361

  Conti, C Richard ^a  

^a NONE

Author keywords

Acute myocardial infarction; Heart failure

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCOSYLATED HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SPIRONOLACTONE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; TROPONIN T;

ACUTE HEART INFARCTION; DIABETES MELLITUS; DRESSLER SYNDROME; DRUG COST; ECHOCARDIOGRAPHY; EDITORIAL; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; INFLAMMATION; MICROALBUMINURIA; MORTALITY; PROGNOSIS; REGISTER; ST SEGMENT ELEVATION;

EID: 23044493993     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960280803     Document Type: Editorial

References (9)

1. Wu AH, Parsons L, Every NR, Bates ER: Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: A report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Med Assoc 2002;40(8):1389-1394
2. Antman EM, Cohen M, Bernink, PJLM, McCabe CH, Horacek T, Papuchis G, Mautner B, Corbalan R, Radley D, Braunwald E: The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. J Am Med Assoc 2000;284:835-842
3. The GUSTO Investigators: Effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med 1993;329:1615-1622
4. Volpi A, DeVita C, Frenzosi MB, Geraci E, Maggioni AP, Mauri F, Negri E, Santoro E, Davazzi L, Tavazzi L, Tgoni G: The Ad Hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico (GISSI) database: Determinants of six month mortality on survivors of myocardial infarction after thrombolysis: Results of the GISSI II Database. Circulation 1993;88:416-429
5. Smock AL, Larson B, Brown C, Conti CR: Early prediction of 30-day mortality afterQ-wave myocardial infarction by echocardiographic assessment of left ventricular function - a pilot investigation. Clin Cardiol 2001;24:191-195
6. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary. J Am Coll Cardiol 2004;44(3):671-719
7. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J, for The Randomized Aldactone Evaluation Study Investigators: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341(10):709-717
8. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M, for the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators: Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348(14):1309-1321:
9. correction published: N Engl J Med 2003;348(22):2271